S
Sina Bavari
Researcher at United States Army Medical Research Institute of Infectious Diseases
Publications - 353
Citations - 21495
Sina Bavari is an academic researcher from United States Army Medical Research Institute of Infectious Diseases. The author has contributed to research in topics: Ebola virus & Virus. The author has an hindex of 69, co-authored 349 publications receiving 18782 citations. Previous affiliations of Sina Bavari include University of Nebraska Medical Center & Walter Reed Army Institute of Research.
Papers
More filters
Journal ArticleDOI
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae.
Jens H. Kuhn,Yiming Bao,Sina Bavari,Stephan Becker,Steven B. Bradfute,J. Rodney Brister,Alexander Bukreyev,Kartik Chandran,Robert A. Davey,Olga Dolnik,John M. Dye,Sven Enterlein,Lisa E. Hensley,Anna N. Honko,Peter B. Jahrling,Karl M. Johnson,Gary P. Kobinger,Eric M. Leroy,Mark S. Lever,Elke Mühlberger,Sergey V. Netesov,Gene G. Olinger,Gustavo Palacios,Jean L. Patterson,Janusz T. Paweska,Louise Pitt,Sheli R. Radoshitzky,Erica Ollmann Saphire,Sophie J. Smither,Robert Swanepoel,Jonathan S. Towner,Guido van der Groen,Viktor E. Volchkov,Victoria Wahl-Jensen,Travis K. Warren,Manfred Weidmann,Stuart T. Nichol +36 more
TL;DR: Adoption of this nomenclature would counter the increasing confusion in genetic variant naming due to the identification of ever more sequences through technological breakthroughs in high-throughput sequencing and environmental sampling and improve figures such as phylograms, alignments, and diagrams.
Journal ArticleDOI
Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever
Kelly L. Warfield,Steven B. Bradfute,Jay Wells,Loreen L. Lofts,Meagan T Cooper,Derron A. Alves,Daniel K Reed,Sean A. Vantongeren,Christine A Mech,Sina Bavari +9 more
TL;DR: It is shown that further sequential passages of MARV-Ravn in immunocompetent mice caused the MARV to kill BALB/c mice and may also help to provide a better understanding of the virulence factors associated with MARV.
Journal ArticleDOI
Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.
Maryam Keshtkar-Jahromi,Jens H. Kuhn,Iva Christova,Steven B. Bradfute,Peter B. Jahrling,Sina Bavari +5 more
TL;DR: The development of prophylaxis and therapy forCrimean-Congo hemorrhagic fever is reviewed and the future prospects for vaccine and drug development are discussed, including that of CCHF-immunoglobulin, which is also in use, but without clear evidence of efficacy.
Journal ArticleDOI
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection
Kelly L. Warfield,Dana L. Swenson,Diane L. Negley,Alan L. Schmaljohn,M. Javad Aman,Sina Bavari +5 more
TL;DR: Findings suggest that VLPs are a promising vaccine candidate for the deadly filovirus infections.
Journal ArticleDOI
Ebola and Marburg virus-like particles activate human myeloid dendritic cells.
Catharine M. Bosio,Brian D Moore,Kelly L. Warfield,Gordon Ruthel,Mansour Mohamadzadeh,M. Javad Aman,Sina Bavari +6 more
TL;DR: DC stimulated with EBOV or MARV VLPs showed enhanced ability to support human T-cell proliferation in an allogenic mixed lymphocyte response (MLR) and have potential in enhancing innate and adaptive immune responses.